Knowledge Distillery

After acute coronavirus disease-2019 (COVID-19), people often experience fatigue, "brain fog," or other central neurologic symptoms (neuro-post-acute…

In 2024, the sequalae of the acute phase of coronavirus disease-19 (COVID-19) infection, which include neurological symptoms and are commonly referred…

Between 2.5% and 28% of people infected with SARS-CoV-2 suffer long COVID or persistence of symptoms for months after acute illness. Many symptoms are…

Previous reports and meta-analyses derived from small case series reported a mortality rate of up to 40% in patients with coronavirus disease 2019…

In October 2020, the European Academy of Neurology (EAN) consensus statement for management of patients with neurological diseases during the…

The authors studied blood-brain barrier (BBB) dysfunction in patients during acute SARS-Cov2 infection (76 inpatients and 25 pre-pandemic controls).…

This longitudinal study analysed digital cognitive tests’ data measuring executive functions (EF) and working memory (WM) from 3142 older adults (> 50…

Respiratory infection with SARS-CoV-2 causes systemic vascular inflammation and cognitive impairment. In this study the authors sought to identify the…

In this systematic review the authors characterize clinical and neuroimaging features of SARS-CoV-2-related acute necrotizing encephalopathy (ANE).…

At least 15% of patients who recover from acute severe acute respiratory syndrome coronavirus 2 infection experience lasting symptoms ("Long-COVID")…

Case-reports/series and cohorts of Guillain-Barré syndrome (GBS) associated with COVID-19 vaccination have been reported. In this article, a…

COVID-19 patients commonly present with signs of central nervous system and/or peripheral nervous system dysfunction. In this study, the authors show…